Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$0.66 USD
-0.08 (-10.97%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $0.72 +0.06 (9.42%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth D Momentum D VGM
Fundamental Charts
About Dividend Yield (TTM)
Plus Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
PSTV 0.66 -0.08(-10.97%)
Will PSTV be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for PSTV based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for PSTV
Ocular Therapeutix (OCUL) Reports Q2 Loss, Misses Revenue Estimates
Plus (PSTV) Upgraded to Buy: Here's Why
PSTV: What are Zacks experts saying now?
Zacks Private Portfolio Services
Plus Therapeutics (PSTV) Reports Q1 Loss, Misses Revenue Estimates
Nutriband Inc. (NTRB) Reports Q1 Loss, Misses Revenue Estimates
The Cooper Companies (COO) Surpasses Q2 Earnings and Revenue Estimates
Other News for PSTV
12 Health Care Stocks Moving In Thursday's Intraday Session
Plus Therapeutics (PSTV) to Introduce CNSide Diagnostics in Texas by August 2025
Plus Therapeutics says CNSide CSF platform will be available for Texas in August
Biotech Continues This Week's Momentum With Another Key Announcement